Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: Potential for treating Parkinson disease

Journal of Biological Chemistry

Volumn 285, Issue 23, 2010, Pages 17318-17328

  Lee, Moonhee ^a   Tazzari, Valerio ^b   Giustarini, Daniela ^c   Rossi, Ranieri ^c   Sparatore, Anna ^b   Del Soldato, Piero ^d   McGeer, Edith ^a   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d CTG Pharma   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORIES; CELL LINES; CONTRIBUTING FACTOR; DISEASE PROGRESSION; DOPAMINERGIC NEURONS; GLUTATHIONES; HYBRID COMPOUNDS; HYBRID MOLECULES; IN-VIVO; INTERLEUKIN-6; LEVODOPA; MICROGLIA; NEUROBLASTOMA CELLS; NEURONAL LOSS; NEUROPROTECTIVE EFFECTS; PARKINSON DISEASE; STIMULATED CELLS; SUBSTANTIA NIGRA; SUPERNATANTS; TUMOR NECROSIS FACTORS;

CELL CULTURE; FUZZY CONTROL; NEURONS; NITRIC OXIDE; SULFUR DETERMINATION;

HYDROGEN SULFIDE;

ACS 83; ACS 84; ACS 85; ACS 86; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE; GLUTATHIONE; HYDROGEN SULFIDE; INTERLEUKIN 6; LEVODOPA; METHYL 2 [3 (ALLYLDISULFANYL)PROPANAMIDO] 3 (3,4 DIHYDROXYPHENYL)PROPANOATE; METHYL 3 (3,4 DIHYDROXYPHENYL) 2 (2 THIOXO 1,3 DITHIOLE 4 CARBOXAMIDO)PROPANOATE; METHYL 3 (3,4 DIHYDROXYPHENYL) 2 [2 [2 METHOXY 4 (3 THIOXO 3H 1,2 DITHIOL 5 YL)PHENOXY]ACETOAMIDO]PROPANOATE; METHYL 3 (3,4 DIHYDROXYPHENYL) 2 [4 (3 THIOXO 3H 1,2 DITHIOL 4 YL)BENZAMIDO]PROPANOATE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; GLIA CELL; HUMAN; HUMAN CELL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; CELL LINE; CELL LINE, TUMOR; HUMANS; HYDROGEN SULFIDE; INTERLEUKIN-6; LEVODOPA; MITOCHONDRIA; MODELS, BIOLOGICAL; NEUROGLIA; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; PARKINSON DISEASE; RATS; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 77952924546     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M110.115261     Document Type: Article

References (47)

1. Fahn, S. (1991) Am. J. Clin. Nutr. 53, Suppl. 1, 380S-382S
2. Holloway, R. G., Shoulson, I., Fahn, S., Kieburtz, K., Lang, A., Marek, K., McDermott, M., Seibyl, J., Weiner, W., Musch, B., Kamp, C., Welsh, M., Shinaman, A., Pahwa, R., Barclay, L., Hubble, J., LeWitt, P., Miyasaki, J., Suchowersky, O., Stacy, M., Russell, D. S., Ford, B., Hammerstad, J., Riley, D., Standaert, D., Wooten, F., Factor, S., Jankovic, J., Atassi, F., Kurlan, R., Panisset, M., Rajput, A., Rodnitzky, R., Shults, C., Petsinger, G., Waters, C., Pfeiffer, R., Biglan, K., Borchert, L., Montgomery, A., Sutherland, L., Weeks, C., DeAngelis, M., Sime, E., Wood, S., Pantella, C., Harrigan, M., Fussell, B., Dillon, S., Alexander-Brown, B., Rainey, P., Tennis, M., Rost-Ruffner, E., Brown, D., Evans, S., Berry, D., Hall, J., Shirley, T., Dobson, J., Fontaine, D., Pfeiffer, B., Brocht, A., Bennett, S., Daigneault, S., Hodgeman, K., O'Connell, C., Ross, T., Richard, K., and Watts, A. (2004) Arch. Neurol. 61, 1044-1053
3. Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., and Lang, A. E. (2000) N. Engl. J. Med. 342, 1484-1491
4. Hald, A., and Lotharius, J. (2005) Exper. Neurol. 193, 279-290
5. Kostrzewa, R. M., Kostrzewa, J. P., and Brus, R. (2002) Amino. Acids. 23, 57-63
6. Jenner, P. (2008) Nat. Rev. Neurosci. 9, 665-677
7. Hunot, S., and Hirsch, E. C. (2003) Ann. Neurol. 53, Suppl. 3, S49-S60
8. McGeer, P. L., Schwab, C., Parent, A., and Doudet, D. (2003) Ann. Neurol. 54, 599-604
9. McGeer, P. L., and McGeer, E. G. (2008) Mov. Disord. 23, 474-483
10. Tansey, M. G., McCoy, M. K., and Frank-Cannon, T. C. (2007) Exp. Neurol. 208, 1-25
11. Kamoun, P. (2004) Amino Acids 26, 243-254
12. Lee, M., Schwab, C., Yu, S., McGeer, E. G., and McGeer, P. L. (2009) Neurobiol. Aging 30, 1523-1534
13. Yang, G., Wu, L., Jiang, B., Yang, W., Qi, J., Cao, K., Meng, Q., Mustafa, A. K., Mu, W., Zhang, S., Snyder, S. H., and Wang, R. (2008) Science 322, 587-590
14. Kimura, Y., and Kimura, H. (2004) FASEB. J. 18, 1165-1167
15. Nagai, Y., Tsugane, M., Oka, J., and Kimura, H. (2004) FASEB. J. 18, 557-559
16. Lee, S. W., Hu, Y. S., Hu, L. F., Lu, Q., Dawe, G. S., Moore, P. K., Wong, P. T., and Bian, J. S. (2006) Glia 54, 116-124
17. Eto, K., Ogasawara, M., Umemura, K., Nagai, Y., and Kimura. H. (2002) J. Neurosci. 22, 3386-3391
18. Hu, L. F., Wong, P. T., Moore, P. K., and Bian, J. S. (2007) J. Neurochem. 100, 1121-1128
19. Lee, M., Sparatore, A., Del Soldato, P., McGeer, E. G., and McGeer, P. L. (2010) Glia 58, 103-113
20. Hu, L. F., Lu, M., Tiong, C. X., Dawe, G. S., Hu, G., and Bian, J. S. (2010) Aging Cell, in press
21. Li, L., Rossoni, G., Sparatore, A., Lee, L. C., Del Soldato, P., and Moore, P. K. (2007) Free Radic. Biol. Med. 42, 706-719
22. Benavides, G. A., Squadrito, G. L., Mills, R. W., Patel, H. D., Isbell, T. S., Patel, R. P., Darley-Usmar, V. M., Doeller, J. E., and Kraus, D. W. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 17977-17982
23. Adelaere, B., and Guemas, J. P. (1989) Sulfur Letters 10, 31-36
24. Lozac'h, N., and Mollier, Y. (1950) Bulletin de la Societe Chimique de France 1243-1244
25. Dartigues, B., Cambar, J., Trebaul, C., Brelivet, J., and Guglielmetti, R. (1980) Eur. J. Med. Chem. 15, 405-412
26. Muzzi, C., Bertocci, E., Terzuoli, L., Porcelli, B., Ciari, I., Pagani, R., and Guerranti, R. (2008) Biomed. Pharmacother. 62, 253-258
27. Giustarini, D., Dalle-Donne, I., Milzani, A., and Rossi, R. (2009) FEBS J. 276, 4946-4958
28. Klegeris, A., Giasson, B. I., Zhang, H., Maguire, J., Pelech, S., and McGeer. P. L. (2006) FASEB. J. 20, 2000-2008
29. Klegeris, A., Walker, D. G., and McGeer, P. L. (1999) Neuropharmacology 38, 1017-1025
30. Frezza, C., Cipolat, S., and Scorrano, L. (2007) Nature Protocols 2, 287-295
31. Hissin, P. J., and Hilf, R. (1976) Anal. Biochem. 74, 214-226
32. Lee, M., Cho, T., Jantaratnotai, N., Wang, Y. T., McGeer, E. G., and McGeer, P. L. (2010) FASEB J., in press
33. Drukarch, B., Flier, J., Jongenelen, C. A., Andringa, G., and Schoffelmeer, A. N. (2006) J. Neural Transm. 113, 593-598
34. Whiteman, M., Armstrong, J. S., Chu, S. H., Jia-Ling, S., Wong, B. S., Cheung, N. S., Halliwell, B., and Moore, P. K. (2004) J. Neurochem. 90, 765-768
35. Langston, J. W., Forno, L. S., Terrud, J., Reeves, A. G., Kaplan, J. A., and Karluk, D. (1999) Ann. Neurol. 46, 598-605
36. Whitton, P. S. (2007) Br. J. Pharmacol. 150, 963-976
37. Asanuma, M., and Miyazaki, I. (2008) Curr. Pharm. Des. 14, 1428-1434
38. Chen, H., Jacobs, E., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., and Ascherio, A. (2005) Ann. Neurol. 58, 963-967
39. Wahner, A. D., Bronstein, J. M., Bordelon, Y. M., and Ritz, B. (2007) Neurology 69, 1836-1842
40. Powers, K. M., Kay, D. M., Factor, S. A., Zabetian, C. P., Higgins, D. S., Samii, A., Nutt, J. G., Griffith, A., Leis, B., Roberts, J. W., Martinez, E. D., Montimurro, J. S., Checkoway, H., and Payami, H. (2008) Mov. Disord. 23, 88-95
41. Esposito, E., Di Matteo, V., Benigno, A., Pierucci, M., Cresscimanno, G., and Di Giovanni, G. (2007) Exp. Neurol. 205, 295-312
42. Postuma, R. B., and Lang, A. E. (2004) Neurology 63, 886-891
43. Łowicka, E., and Bełtowski, J. (2007) Pharmacol. Rep. 59, 4-24
44. Zoccolella, S., dell'Aquila, C., Abruzzese, G., Antonini, A., Bonuccelli, U., Margherita-Canesi, M., Cristina, S., Marchese, R., Pacchetti, C., Zagaglia, R., Logroscino, G., Defazio, G., Lamberti, P., and Livrea, P. (2009) Mov. Disord. 24, 1028-1033
45. Klegeris, A., and McGeer, P. L. (2000) Exp Neurol. 166, 458-464
46. Damier, P., Kastner, A., Agid, Y., and Hirsch, E. C. (1996) Neurology 46, 1262-1269
47. Nagatsu, T., and Sawada, M. (2006) J Neural Transm Suppl. 71, 53-65